- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Delivery Hero gets $150m Rappi return
Delivery Hero has generated a healthy return having sold part of its stake in delivery app developer Rappi, one of several investments in the Latin American market.
Jan 11, 2022Bluepha manufactures $137m in series B3 funding
Country Garden Venture Capital returned to reinvest in Bluepha having led the the bioplastics developer’s series B2 round five months ago.
Jan 11, 2022SoftBank gets $100m to Gousto
SoftBank is hopping on the meal-kit bandwagon having acquired a stake in Gousto at a valuation of $1.75bn.
Jan 11, 2022Deals: January 11, 2022
Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
Jan 11, 2022Eikon excels at $518m series B
Eikon Therapeutics was co-founded by UC Berkeley researchers, one of whom has already received a Nobel Prize for the underlying technology.
Jan 11, 2022Zluri bags $10m in series A funding
MassMutual Ventures was among the participants as Zluri became the latest software-as-a-service management platform developer to raise money.
Jan 11, 2022Daily Deal Round Up: January 10, 2022
Raw materials provider Vital Thin Film secured $188m in a round co-led by BYD while drug developers CinCor and Vigil raised a total of $292m in their initial public offerings.
Jan 10, 2022Exits: January 10, 2022
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Jan 10, 2022Deals: January 10, 2022
Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
Jan 10, 2022Carsome drives to $290m in series E
Gokongwei, Sunway and YTL are among the participants in the vehicle resale platform developer’s latest round, which reportedly included Mediatek and Taiwan Mobile, at a $1.7bn valuation.
Jan 10, 2022Korro Bio concludes $116m series B
All existing shareholders including Alexandria Venture Investments contributed to the RNA drug developer’s series B round, following a $91.5m series A in mid-2020.
Jan 10, 2022Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


